Vaneck Vectors Global Health Leaders ETF (ASX:HLTH)
Australia · Delayed Price · Currency is AUD 11.95
+0.02 (0.17%)
Last updated: Sep 1, 2026, 1:33 PM AEST
ASX:HLTH Holdings Information
ASX:HLTH is an equity ETF with a total of 10 individual holdings. The top holdings are Illumina stock at 3.24%, Halozyme Therapeutics at 3.02%, Arrowhead Pharmaceuticals at 2.87%, West Pharmaceutical Services at 2.72%, and argenx SE at 2.68%.
Total Holdings
10
Top 10 Percentage
26.92%
Asset Class
Equity
ETF Category
Health Care
Assets
57.93M
PE Ratio
21.42
Breakdown by Country
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | ILMN | Illumina, Inc. | 3.24% |
| 2 | HALO | Halozyme Therapeutics, Inc. | 3.02% |
| 3 | ARWR | Arrowhead Pharmaceuticals, Inc. | 2.87% |
| 4 | WST | West Pharmaceutical Services, Inc. | 2.72% |
| 5 | ARGX | argenx SE | 2.68% |
| 6 | SWX: YPSN | Ypsomed Holding AG | 2.63% |
| 7 | DXCM | DexCom, Inc. | 2.54% |
| 8 | INCY | Incyte Corporation | 2.49% |
| 9 | KOSDAQ: 196170 | ALTEOGEN Inc. | 2.37% |
| 10 | EXEL | Exelixis, Inc. | 2.36% |
As of Aug 20, 2026